ONCOSENX
OncoSenX is a developer of transient gene therapies designed for solid tumors. The company's therapy delivers plasmid DNA with a novel lipid nanoparticle that selectively kills cancerous cells based on their transcriptional activity, providing cancer patients, doctors and medical care professionals with a less invasive and more precise intervention for this complex and devastating disease.
ONCOSENX
Social Links:
Industry:
Biotechnology Health Care
Founded:
2017-01-01
Address:
Seattle, Washington, United States
Country:
United States
Website Url:
http://www.oncosenx.com
Total Employee:
1+
Status:
Active
Total Funding:
11.7 M USD
Technology used in webpage:
Google Apps For Business Squarespace Hosted
Similar Organizations
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
Obsidian Therapeutics
Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.
Current Advisors List
Current Employees Featured
Founder
Investors List
Althea Ventures
Althea Ventures investment in Seed Round - OncoSenX
Canadian Institutes of Health Research
Canadian Institutes of Health Research investment in Grant - OncoSenX
Jim Mellon
Jim Mellon investment in Pre Seed Round - OncoSenX
SENS Foundation
SENS Foundation investment in Pre Seed Round - OncoSenX
Helios Capital
Helios Capital investment in Pre Seed Round - OncoSenX
Kingsley Advani
Kingsley Advani investment in Pre Seed Round - OncoSenX
Kingsley Advani
Kingsley Advani investment in Pre Seed Round - OncoSenX
Benjamin Kong
Benjamin Kong investment in Pre Seed Round - OncoSenX
Avant Global
Avant Global investment in Seed Round - OncoSenX
Official Site Inspections
http://www.oncosenx.com Semrush global rank: 5.99 M Semrush visits lastest month: 1.37 K
- Host name: 198.185.159.144
- IP address: 198.185.159.144
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "OncoSenX"
OncoSenX - Crunchbase Company Profile & Funding
OncoSenX is a developer of transient gene therapies designed for solid tumors. The company's therapy delivers plasmid DNA with a novel lipid nanoparticle …See details»
OncoSenX Company Profile | Management and Employees List
OncoSenX Profile and History OncoSenX is a late preclinical-stage oncology company developing therapeutics to kill cancer cells based on their genetics. Headquartered in Seattle, …See details»
OncoSenX Company Profile - Office Locations, Competitors ... - Craft
OncoSenX has 5 employees at their 1 location and $3 m in total funding,. See insights on OncoSenX including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
OncoSenX 2025 Company Profile: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for OncoSenX. Use the PitchBook Platform to explore the full profile.See details»
OncoSenX - Funding, Financials, Valuation & Investors
OncoSenX is a developer of transient gene therapies designed for solid tumors.See details»
OncoSenX, Inc. Company Profile | Seattle, WA - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for OncoSenX, Inc. of Seattle, WA. Get the latest business insights from Dun & Bradstreet.See details»
OncoSenX - VentureRadar
"OncoSenX is a late stage pre-clinical cancer company headquartered in Seattle, Washington. OncoSenX targets solid tumors based on transcriptional activity using a unique lipid …See details»
OncoSenX Company Profile Funding & Investors
OncoSenX is a late stage pre-clinical cancer company headquartered in Seattle, Washington. OncoSenX targets solid tumors based on transcriptional activity using a unique Proteo-Lipid Vehicle (PLV ...See details»
OncoSenX - Products, Competitors, Financials, Employees, …
About OncoSenX OncoSenX is a biotechnology company focused on the development of targeted cancer therapies. The company specializes in treatments that induce apoptosis in cancerous …See details»
OncoSenX - Contacts, Employees, Board Members, Advisors
OncoSenX has 4 current employee profiles, including Chief Business Officer Stephen Hilbert. OncoSenX has 1 board member or advisor, Kristin Bedard.See details»
OncoSenX Overview | SignalHire Company Profile
OncoSenX is a private company that has been in the industry for 5 years. The company currently specializes in the Biotechnology area. The position of the CEO is occupied by Matthew …See details»
OncoSenX | EdgeIn undefined Company Profile - Contact …
OncoSenX is a late stage pre-clinical cancer company headquartered in Seattle, Washington. OncoSenX targets solid tumors based on transcriptional activity using a unique lipid …See details»
OncoSenX | VentureRadar
OncoSenX is a late stage pre-clinical cancer company headquartered in Seattle, Washington. OncoSenX targets solid tumors based on transcriptional activity using a unique lipid …See details»
OncoSenX Raises $3 Million to Advance New Class of Cancer …
Jul 8, 2019 SEATTLE-- (BUSINESS WIRE)--OncoSenX, Inc., a late preclinical-stage company developing therapeutics to kill cancer cells based on their genetics, today announced it has …See details»
OncoSenX closes $3 million funding to accelerate the preclinical ...
Jul 8, 2019 OncoSenX, a late preclinical-stage startup developing therapeutics to kill cancer cells based on their genetics, today announced it has raised $3 million in pre-seed funding to …See details»
Seattle biotech startup OncoSenX raising more cash for
May 11, 2020 Biotech startup OncoSenX is raising more cash to help support its pipeline of therapeutics that aim to kill cancer cells based on their genetics.See details»
Seattle biotech startup OncoSenX raises $3M to develop tumor …
Jul 9, 2019 Story updated with comments from Scholz below. Seattle biotech startup OncoSenX has reeled in $3 million to advance its pipeline of therapeutics that aimSee details»
OncoSenX - Tech Stack, Apps, Patents & Trademarks - Crunchbase
OncoSenX is a developer of transient gene therapies designed for solid tumors.See details»
Cancer Therapeutics Company OncoSenX Secures $3 Million
Jul 11, 2019 OncoSenX — a late preclinical-stage company developing therapeutics for killing cancer cells based on their genetics — announced it raised $3 million in pre-seed funding to …See details»